Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Statistics

Total Valuation

STO:CLBIO has a market cap or net worth of SEK 405.97 million. The enterprise value is 385.42 million.

Market Cap	405.97M
Enterprise Value	385.42M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:CLBIO has 25.61 million shares outstanding. The number of shares has increased by 13.40% in one year.

Current Share Class	25.61M
Shares Outstanding	25.61M
Shares Change (YoY)	+13.40%
Shares Change (QoQ)	+3.98%
Owned by Insiders (%)	45.89%
Owned by Institutions (%)	5.19%
Float	9.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.28
PB Ratio	4.33
P/TBV Ratio	4.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.19
EV / Sales	44.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.73

Financial Position

The company has a current ratio of 4.98

Current Ratio	4.98
Quick Ratio	4.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14,785.00

Financial Efficiency

Return on equity (ROE) is -16.29% and return on invested capital (ROIC) is -10.23%.

Return on Equity (ROE)	-16.29%
Return on Assets (ROA)	-9.56%
Return on Invested Capital (ROIC)	-10.23%
Return on Capital Employed (ROCE)	-15.77%
Weighted Average Cost of Capital (WACC)	6.38%
Revenue Per Employee	715,500
Profits Per Employee	-1.23M
Employee Count	13
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.71% in the last 52 weeks. The beta is 0.39, so STO:CLBIO's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+57.71%
50-Day Moving Average	16.71
200-Day Moving Average	15.26
Relative Strength Index (RSI)	46.85
Average Volume (20 Days)	20,813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLBIO had revenue of SEK 8.59 million and -14.71 million in losses. Loss per share was -0.59.

Revenue	8.59M
Gross Profit	6.23M
Operating Income	-14.79M
Pretax Income	-14.71M
Net Income	-14.71M
EBITDA	-14.68M
EBIT	-14.79M
Loss Per Share	-0.59

Balance Sheet

The company has 20.56 million in cash and n/a in debt, with a net cash position of 20.56 million or 0.80 per share.

Cash & Cash Equivalents	20.56M
Total Debt	n/a
Net Cash	20.56M
Net Cash Per Share	0.80
Equity (Book Value)	93.76M
Book Value Per Share	3.66
Working Capital	19.16M

Cash Flow

In the last 12 months, operating cash flow was -17.69 million and capital expenditures -47,000, giving a free cash flow of -17.74 million.

Operating Cash Flow	-17.69M
Capital Expenditures	-47,000
Free Cash Flow	-17.74M
FCF Per Share	-0.69

Margins

Gross margin is 72.51%, with operating and profit margins of -172.20% and -171.37%.

Gross Margin	72.51%
Operating Margin	-172.20%
Pretax Margin	-171.37%
Profit Margin	-171.37%
EBITDA Margin	-170.99%
EBIT Margin	-172.20%
FCF Margin	n/a

Dividends & Yields

STO:CLBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.40%
Shareholder Yield	-13.40%
Earnings Yield	-3.62%
FCF Yield	-4.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:CLBIO has an Altman Z-Score of 36.95 and a Piotroski F-Score of 1.

Altman Z-Score	36.95
Piotroski F-Score	1